EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro synergistic activity of betulinic acid combined with azoles against pathogenic fungi

Heng Zhang, Lu Ge, Mengqi Peng, Menghua Tang, Yixin Zeng, Chunmiao Sun, Yi Sun

Frontiers in Microbiology · 24.06.2026 · 17

DOI: 10.3389/fmicb.2026.1835794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 24.06.2026. Verfasst von Heng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital…. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections and emerging antifungal resistance threaten global public health, demanding effective combination therapies.

Objective

To evaluate in vitro synergistic antifungal activity of betulinic acid (BA) combined with four azoles (itraconazole [ITR], voriconazole [VOR], posaconazole [POS], fluconazole [FLC]) against Aspergillus spp., Candida spp., Exophiala dermatitidis , and Cryptococcus neoformans .

Methods

Per CLSI M27–A3/M38–A2, broth microdilution checkerboard assay determined BA’s minimum inhibitory concentration (MIC) and synergy with azoles ( n = 110); flow cytometry measured intracellular reactive oxygen species (ROS) in fungi co–cultured with BA.

Results

BA alone had no antifungal activity, but showed synergy with specific azoles: BA/POS had 82.7% (43/52) synergy against Aspergillus spp., 95.2% (20/21) against E. dermatitidis , and 70% (7/10) against Candida auris (of 28 Candida spp., 28.6% synergy). BA/FLC had 55.6% (5/9) synergy against C. neoformans . Among the 110 strains, the synergy rates of BA with POS, ITR and VOR were 66.4, 10.9 and 2.7%, respectively; the BA–FLC synergy rate was 18.5% in 27 strains. BA/POS co–culture increased fungal ROS.

Conclusion

BA–POS reduces POS’s MIC and exerts potent synergy against Aspergillus spp. and E. dermatitidis. BA has potential as an adjuvant for treating Aspergillus and E. dermatitidis infections.

Schlagwörter

Stichwörter der Autor:innen

AspergillusExophiala dermatitidisbetulinic acidinvasive fungal infectionsposaconazolesynergistic effect

Autor:innen und Institutionen

  • Department of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, Hubei Province, China.
  • Department of Clinical Medicine, Yangtze University, Jingzhou, Hubei Province, China.
  • Department of Clinical Laboratory, Jingzhou Hospital Affiliated to Yangtze University, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou, Hubei Province, C…

Zitieren

APA

Zhang, H., Ge, L., Peng, M., Tang, M., Zeng, Y., Sun, C., & Sun, Y. (2026). In vitro synergistic activity of betulinic acid combined with azoles against pathogenic fungi. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1835794

Vancouver

Zhang H, Ge L, Peng M, Tang M, Zeng Y, Sun C, et al. In vitro synergistic activity of betulinic acid combined with azoles against pathogenic fungi. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1835794

BibTeX
@article{Zhang2026,
  author = {Zhang, Heng and Ge, Lu and Peng, Mengqi and Tang, Menghua and Zeng, Yixin and Sun, Chunmiao and Sun, Yi},
  title = {In vitro synergistic activity of betulinic acid combined with azoles against pathogenic fungi},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1835794}
}
Kostenlos starten →